日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

c-Kit Mutation and Localization Status as Response Predictors in Mast Cell Tumors in Dogs Treated with Prednisone and Toceranib or Vinblastine

c-Kit突变和定位状态作为犬肥大细胞瘤患者接受泼尼松和托西拉尼或长春碱治疗的疗效预测因子

Weishaar, K M; Ehrhart, E J; Avery, A C; Charles, J B; Elmslie, R E; Vail, D M; London, C A; Clifford, C A; Eickhoff, J C; Thamm, D H

Breed Distribution and Clinical Characteristics of B Cell Chronic Lymphocytic Leukemia in Dogs

犬B细胞慢性淋巴细胞白血病的品种分布和临床特征

Bromberek, J L; Rout, E D; Agnew, M R; Yoshimoto, J; Morley, P S; Avery, A C

Pulse-Administered Toceranib Phosphate Plus Lomustine for Treatment of Unresectable Mast Cell Tumors in Dogs.

脉冲式给药磷酸托西拉尼联合洛莫司汀治疗犬类不可切除的肥大细胞瘤

Burton J H, Venable R O, Vail D M, Williams L E, Clifford C A, Axiak-Bechtel S M, Avery A C, Thamm D H

Flow cytometric characterization and clinical outcome of CD4+ T-cell lymphoma in dogs: 67 cases

犬CD4+ T细胞淋巴瘤的流式细胞术特征分析及临床结局:67例病例

Avery, P R; Burton, J; Bromberek, J L; Seelig, D M; Elmslie, R; Correa, S; Ehrhart, E J; Morley, P S; Avery, A C

Canine T-zone lymphoma: unique immunophenotypic features, outcome, and population characteristics

犬T区淋巴瘤:独特的免疫表型特征、预后和群体特征

Seelig, D M; Avery, P; Webb, T; Yoshimoto, J; Bromberek, J; Ehrhart, E J; Avery, A C

Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors.

针对可测量的犬肥大细胞瘤,开展低分割放射治疗、托西拉尼和泼尼松的多中心前瞻性试验

Carlsten K S, London C A, Haney S, Burnett R, Avery A C, Thamm D H